Protein Domains Governing Interactions Between E2F, the Retinoblastoma Gene Product, and Human Papillomavirus type 16 E7 Protein

References

• Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659–669.
   PubMed Web of Science ®Google Scholar
• Bagchi, S., R. Weinmann, and P. Raychaudhuri. 1991. The retinoblastoma protein copurifies with E2F-I, an E1a-regulated inhibitor of the transcription factor E2F. Cell 65:1063–1072.
   PubMed Web of Science ®Google Scholar
• Baker, C. C., W. C. Phelps, V. Lindgren, Μ. J. Braun, Μ. A. Gonda, and P. Μ. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962–972.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., J. P. Adamszewski, T. Hunt, and J. B. LaThangue. 1991. Cyclin A and the retinoblastoma gene product complex with a common transcription factor. Nature (London) 352:249–251.
   PubMed Web of Science ®Google Scholar
• Barbosa, J. S., C. Edmonds, C. Fisher, J. T. Schiller, D. R. Lowy, and K. H. Vousden. 1990. The region of the HPV E7 oncoprotein homologous to adenovirus E1A and SV40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J. 9:153–160.
   PubMed Web of Science ®Google Scholar
• Barbosa, Μ. S., D. R. Lowy, and J. T. Schiller. 1989. Papillomavirus polypeptides E7 and E7 are zinc-binding proteins. J. Virol. 3:1404–1407.
   Google Scholar
• Chellapan, S., V. B. Kraus, B. Kroger, K. Munger, P. Μ. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549–4553.
   PubMedGoogle Scholar
• Chellappan, S. P., S. Hiebert, Μ. Mudryj, J. Μ. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Chittenden, T., D. Μ. Livingston, and W. G. Kaelin. 1991. The T/ElA-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell 65:1073–1082.
   PubMed Web of Science ®Google Scholar
• Cooper, J. A., and P. Whyte. 1989. RB and the cell cycle: entrance or exit? Cell 58:1009–1011.
   PubMedGoogle Scholar
• Coutlee, F., K. V. Shah, J. S. Rader, J. L. Currie, and R. P. Viscidi. 1991. Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization. J. Clin. Microbiol. 29:968–974.
   PubMedGoogle Scholar
• Crook, T., J. P. Morgenster, L. Crawford, and L. Banks. 1989. Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J. 8:513–519.
   PubMed Web of Science ®Google Scholar
• Defeo-Jones, D., P. S. Huang, R. E. Jones, K. Μ. Haskell, G. A. Vuocolo, Μ. G. Hanobik, H. E. Huber, and A. Oliff. 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (London) 352:251–254.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. Μ. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dyson, N., R. Bernards, S. H. Friend, L. R. Gooding, J. A. Hassell, E. O. Major, J. Μ. Pipas, T. VanDyke, and E. Harlow. 1990. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol. 64:1353–1356.
   PubMed Web of Science ®Google Scholar
• Dyson, N., P. Μ. Howley, K. Munger, and E. Harlow. 1989. The human papilloma virus-16 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934–937.
   PubMed Web of Science ®Google Scholar
• Edmonds, C., and J. K. Vousden. 1989. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:2650–2656.
   PubMedGoogle Scholar
• Edwards, G., H. E. Huber, D. DeFeo-Jones, G. Vuocolo, P. J. Goodhart, R. Z. Maigetter, G. Sanyal, A. Oliff, and D. C. Heimbrook. 1992. Purification and characterization of a functionally homogeneous 60-kDa species of the retinoblastoma gene product. J. Biol. Chem. 267:7971–7974.
   PubMedGoogle Scholar
• Ewen, Μ. E., Y. Xing, J. B. Lawrence, and D. Μ. Livingston. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for pl07, a retinoblastoma gene product-related protein. Cell 66:1155–1164.
   PubMed Web of Science ®Google Scholar
• Helin, K., J. A. Lees, Μ. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., Μ. Blake, J. Azizkhan, and J. R. Nevins. 1991. Role of E2f transcription factor in ElA-mediated trans activation of cellular genes. J. Virol. 65:3547–3552.
   PubMedGoogle Scholar
• Hiebert, S. W., S. P. Chellappan, J. Μ. Horowitz, and J. R. Nevins. 1992. The interaction of Rb with E2F coincides with an inhibition of the transactivation activity of E2F. Genes Dev. 6:177–185.
   PubMed Web of Science ®Google Scholar
• Hu, Q., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus Ela or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147–1155.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, Μ. A. Blanar, D. Μ. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-like protein with E2F-like properties. Cell 70:351–364.
   PubMed Web of Science ®Google Scholar
• Kanda, T., A. Furono, and K. Yoshiike. 1988. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J. Virol. 62:610–613.
   PubMed Web of Science ®Google Scholar
• Jones, R. E., D. C. Heimbrook, H. E. Huber, R. J. Wegrzyn, N. S. Rotberg, K. J. Stauffer, P. K. Lumma, V. Μ. Garsky, and A. Oliff. 1992. Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor protein. J. Biol. Chem. 267:908–912.
   PubMedGoogle Scholar
• Jones, R. E., R. J. Wegrzyn, D. R. Patrick, N. L. Balishin, G. A. Vuocolo, Μ. W. Riemen, D. Defeo-Jones, V. Μ. Garsky, D. C. Heimbrook, and A. Oliff. 1990. Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J. Biol. Chem. 265:12782–12785.
   PubMed Web of Science ®Google Scholar
• Matlashewski, G., J. Schneider, L. Banks, L. Jones, A. Murray, and L. Crawford. 1987. Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6:1741–1746.
   PubMed Web of Science ®Google Scholar
• Mudryj, Μ., S. H. Devoto, S. W. Heibert, T. Hunter, J. Pines, and J. R. Nevins. 1991. Cell cycle regulation of the E2F transcription factor involves and interaction with cyclin A. Cell 65:1243–1253.
   PubMed Web of Science ®Google Scholar
• Munger, K., W. C. Phelps, V. Bubb, P. Μ. Howley, and R. Schlegel. 1989. The E7 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417–4421.
   PubMed Web of Science ®Google Scholar
• Munger, K., C. L. Yee, W. C. Phelps, J. A. Pietenpol, H. Moses, and P. Μ. Howley. 1991. Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomaviruses are determined by amino-terminal sequences. J. Virol. 65:3943–3948.
   PubMed Web of Science ®Google Scholar
• Patrick, D. E., K. Zhang, D. Defeo-Jones, G. R. Vuocolo, R. Z. Maigetter, Μ. K. Sardana, A. Oliff, and D. C. Heimbrook. 1992. Characterization of functional HPV-16 protein produced in E. coli. J. Biol. Chem. 267:6910–6915.
   PubMedGoogle Scholar
• Phelps, W. C., S. Bagchi, J. A. Varnes, P. Raychaudhuri, V. Draus, K. Junger, P. Μ. Howley, and J. R. Nevins. 1991. Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S ElA suggests a common mechanism. J. Virol. 65:6922–6930.
   PubMedGoogle Scholar
• Phelps, W. C., K. Munger, C. L. Yee, J. A. Barnes, and P. Μ. Howley. 1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66:2418–2427.
   PubMedGoogle Scholar
• Phelps, W. C., C. L. Yee, K. Munger, and P. Μ. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539–547.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Krauss, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus ElA protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200–1211.
   PubMedGoogle Scholar
• Shirodkar, S., Μ. Ewen, J. A. DeCaprio, J. Morgan, D. Μ. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a pl07-cyclinA complex in a cell cycle-regulated manner. Cell 68:157–166.
   PubMed Web of Science ®Google Scholar
• Stirdivant, S. Μ., J. D∙ Ahern, A. Oliff, and D. C. Heimbrook. 1992. Retinoblastoma protein binding properties are dependent on four cysteine residues in the protein binding pocket. J. Biol. Chem. 267:14846–14851.
   PubMedGoogle Scholar
• Stirdivant, S. Μ., H. E. Huber, D. R. Patrick, D. Defeo-Jones, E. Μ. McAvoy, V. Μ. Garsky, A. Oliff, and D. C. Heimbrook. 1992. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product. Mol. Cell. Biol. 12:1905–1914.
   PubMedGoogle Scholar
• Wang, N. P., P. L. Chen, S. Huang, A. Donoso, W.-H. Lee, and E. Y.-H. P. Lee. 1990. DNA binding activity of retinoblastoma protein is intrinsic to its carboxyl-terminal region. Cell Growth Differ. 1:233–239.
   PubMedGoogle Scholar
• Watanabe, S., T. Kanda, S. Hironori, A. Furuno, and K. Yoshiike. 1990. Mutational analysis of human papillomavirus type 16 E7 functions. J. Virol. 64:207–214.
   PubMedGoogle Scholar
• Watanabe, S., U. Kanda, and K. Yoshiike. 1989. Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7. J. Virol. 632:965–968.
   Google Scholar
• Whyte, P., J. J. Buckovich, J. Μ. Horowitz, S. H. Friend, Μ. Raybuch, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus ElA proteins bind to the retinoblastoma gene product. Nature (London) 334:124–129.
   PubMed Web of Science ®Google Scholar
• Whyte, P., N. Μ. Willamson, and E. Harlow. 1989. Cellular targets for transformation by the adenovirus ElA proteins. Cell 56:67–75.
   PubMed Web of Science ®Google Scholar
• Yee, A. S., P. Raychaudhuri, L. Jakoi, and J. R. Nevins. 1989. The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding. Mol. Cell. Biol. 92:578–585.
   Google Scholar
• Yee, C., I. Krishnan-Hewlett, C. Baker, R. Schlegel, and P. Μ. Howley. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 119:363–366.
   Google Scholar
• zur Hausen, H., and A. Schneider. 1987. p. 245–263. In P. Μ. Howley and N. P. Salzman (ed.), The Papovaviride, vol. 2. The papillomaviruses. Plenum, New York.
   Google Scholar